HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osteochondrosis (Osgood Schlatter Disease)

Any of a group of bone disorders involving one or more ossification centers (EPIPHYSES). It is characterized by degeneration or NECROSIS followed by revascularization and reossification. Osteochondrosis often occurs in children causing varying degrees of discomfort or pain. There are many eponymic types for specific affected areas, such as tarsal navicular (Kohler disease) and tibial tuberosity (Osgood-Schlatter disease).
Also Known As:
Osgood Schlatter Disease; Koehler's Disease; Navicular Osteochondrosis; Koehlers Disease; Navicular Osteochondroses; Osteochondroses; Osteochondroses, Navicular; Osteochondrosis, Navicular; Koehler Disease; Osgood-Schlatter Disease
Networked: 462 relevant articles (22 outcomes, 38 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Neurologic Manifestations (Neurological Manifestations)
2. Pain (Aches)
3. Tendinopathy (Tendonitis)
4. Myocardial Ischemia (Ischemic Heart Diseases)
5. Osteochondrodysplasias (Spondyloepiphyseal Dysplasia)

Experts

1. Semevolos, Stacy A: 7 articles (01/2022 - 11/2002)
2. van Weeren, P R: 5 articles (11/2013 - 02/2000)
3. Distl, O: 5 articles (11/2009 - 01/2006)
4. Kovalenko, A L: 3 articles (01/2021 - 01/2017)
5. Parfenov, S A: 3 articles (01/2021 - 01/2017)
6. Vasilevskaya, M A: 3 articles (01/2021 - 01/2017)
7. Chiaradia, Elisabetta: 3 articles (01/2020 - 07/2012)
8. Laverty, S: 3 articles (05/2018 - 05/2000)
9. Carlson, C S: 3 articles (09/2016 - 12/2000)
10. McIlwraith, C Wayne: 3 articles (07/2013 - 02/2004)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Osteochondrosis:
1. Phosphorus (Red Phosphorus)IBA
2. CalciumIBA
3. RadonIBA
4. Insulin-Like Growth Factor I (IGF-1)IBA
5. hydroxide ionIBA
09/29/2017 - "FokI, BsmI, ApaI, and TaqI VDR-polymorphisms were detected through PCR-restriction fragment length polymorphism (RFLP), and circulating 25(OH)D, CTx-I and CTx-II were measured by immunoassays in 79 patients (of which 26 had osteochondrosis) and 79 age-, sex- and body mass index (BMI)-matched healthy controls. "
06/01/2003 - "It is suggested that in GD, increased calcitonin levels and/or a relative deficiency in 24,25(OH)2D3 at the growth-plate level may both be responsible for the retarded maturation of chondrocytes, resulting in retained cartilage cones and osteochondrosis, and this may be a pathophysiological factor for the increased susceptibility of large breed dogs to developing skeletal disorders."
01/01/1989 - "The incidence of osteochondrosis at 2 weeks was, respectively, 0/8, 0/8, 0/8, 0/8, 0/8, and 1/8, and at 4 weeks was, respectively, 0/8, 0/8, 0/8, 2/8, 2/8 and 2/8. The NRC (1988) estimate of the requirement for vitamin D may be somewhat low since the concentration of plasma 25(OH)D was lower with 200 or 1,000 IU vitamin D/kg diet than at the start."
11/29/2002 - "Large-breed pups fed on a standard diet supplemented with Ca and P had decreased plasma concentrations of both 25(OH)D(3) and 1,25(OH)(2)D(3), which may indicate an increased clearance of these metabolites; the low plasma concentrations of the di-hydroxylated vitamin D metabolites were considered responsible for the disturbance in cartilage maturation (i.e., osteochondrosis) in these dogs. "
09/29/2017 - "We evaluated the association between the circulating 25-hydroxyvitamin D (25(OH)D) type I and II collagen degradation products (CTx-I, and CTx-II), and four vitamin D receptor gene (VDR) polymorphisms, in Italian males affected by low back pain (LBP) due to herniation/discopathy and/or vertebral osteochondrosis. "
6. Trace Elements (Biometals)IBA
7. Propranolol (Inderal)FDA LinkGeneric
8. CollagenIBA
9. PapainIBA
10. Proteoglycans (Proteoglycan)IBA

Therapies and Procedures

1. Osteotomy
2. Conservative Treatment
3. Therapeutics
4. Lasers (Laser)
5. Injections